eEML - Electronic Essential Medicines List

export

Export

Cytarabine

Essential medicine status

General description

Cytarabine is a pyrimidine nucleoside analogue antineoplastic agent used in the treatment of leukaemias and lymphomas.

INN

Cytarabine

ATC codes

Medicine type

Chemical agent

EML status history

First added in 1979 (TRS 641) for Lymphoid leukaemia, not elsewhere classified

Added in 1979 (TRS 641) for Myeloid leukaemia

Added in 1979 (TRS 641) for Burkitt lymphoma including Burkitt leukaemia

Added in 1979 (TRS 641) for Acute myeloid leukaemia with recurrent genetic abnormalities

Added in 1979 (TRS 641) for Unspecified malignant neoplasms of ill-defined or unspecified sites

Removed in 2015 (TRS 994) for Unspecified malignant neoplasms of ill-defined or unspecified sites

Wikipedia

DrugBank

Recommendations

Parenteral > General injections > unspecified: 100 mg in vial powder for injection

Indications

Lymphoid leukaemia, not elsewhere classified Myeloid leukaemia Acute myeloid leukaemia with recurrent genetic abnormalities Burkitt lymphoma including Burkitt leukaemia Unspecified malignant neoplasms of ill-defined or unspecified sites